MEDNAX to Host Two Premier Neonatology Meetings Feb. 17-22

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--MEDNAX, Inc. (NYSE: MD), the nation’s leading provider of maternal-fetal, newborn and pediatric subspecialty care, will host two premier meetings in neonatal medicine this month at the Manchester Grand Hyatt in San Diego. Specialty Review in Neonatology and NEO: The Conference for Neonatology will take place concurrently, each addressing many of the most critical and controversial issues that influence the clinical practice of newborn medicine. The meetings will host more than 700 combined attendees.

Specialty Review in Neonatology | Feb. 17-22

Celebrating its 10^th anniversary, Specialty Review is the country’s leading review of its type, offering an intensive and comprehensive review of neonatal medicine. The course is invaluable to those preparing for subspecialty certifying examinations, as well as new or current fellows in training seeking a fundamental pathophysiology and problem-based review of neonatal-perinatal medicine.

Directed by David Weisoly, D.O., MEDNAX-affiliated neonatologist, the six-day course will feature an elite lineup of world-renowned speakers known for their excellence in teaching and field expertise. Attendees will also have the opportunity to participate in the popular “Battle of the Boards” event. Now in its fifth year, the Jeopardy-style rapid-fire team competition is designed to enhance the learning experience in a fun, interactive setting.

For more information, visit www.specialtyreview.com.

NEO: The Conference for Neonatology | Feb. 19-21

NEO has established a reputation as the top neonatology meeting in the U.S. Directed by Reese Clark, M.D., Vice President of Clinical Research for MEDNAX, and Timothy Biela, M.D., MEDNAX-affiliated neonatologist, NEO continues its longstanding tradition of providing the latest information on key areas of neonatal management. The goal of the meeting continues to be the improvement of neonatal outcomes through expert discussions of optimal approaches in the neonatal intensive care unit (NICU).

An esteemed panel of speakers comprised of well-recognized faculty from top institutions across the country as well as several MEDNAX-affiliated physicians will present over the course of three days. New to this year’s agenda is “Ask the Expert!,” a roundtable discussion focusing on respiratory treatments in the NICU and early onset sepsis.

For more information, visit www.neoconference.com.

Specialty Review and NEO are accredited by the MEDNAX Center for Research, Education, Quality and Safety, providing continuing medical and nursing education credit for participating clinicians.

ABOUT MEDNAX

MEDNAX, Inc. is a national health solutions partner comprised of the nation's leading providers of physician services. Physicians and advanced practitioners practicing as part of MEDNAX are reshaping the delivery of care within their specialties and subspecialties, using evidence-based tools, continuous quality initiatives, consulting services, clinical research and telemedicine to enhance patient outcomes and provide high-quality, cost-effective care. The Company was founded in 1979, and today, through its affiliated professional corporations, MEDNAX provides services through a network of more than 4,325 physicians in all 50 states and Puerto Rico. Additional information is available at www.mednax.com.